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ABSTRACT

Disclosed are fluorescent compounds useful as intracellular
pH probes. In particular, the invention teaches a two-photon
absorbing, water soluble, fluorescent compound, a fluorene
derivative, which is effective as a near-neutral pH indicator
and particularly as an intracellular probe. A method for
chemical synthesis of the claimed compounds is provided.
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TWO-PHOTON ABSORBING WATER
SOLUBLE FLUORESCENT PROBE AS A
NEAR NEUTRAL PH INDICATOR

7-(benzo[d]thiazol-2-yl)-N,N-dipheny 9H-fluoren-2-amine
other 2PA chromophores (la and 1b, FIG. 1) developed in our
group, and is used as anexample.I 6 The compounds la and lb
have been demonstrated to possess high 2PA cross-sections,
i.e. -100 GM, almost unity fluorescent quantum yield and
high photo stability. I?. Is However, these two compounds are
rather hydrophobic, which limited their applications in aqueous biological environments. Therefore, compound le is specifically designed to improve the water-solubility by introduction of the dipropionic carboxylic acid at 9-position of the
fluorene ring, and the diphenylamino groups in la and lb
were replaced by diethyltheamino group to adjust the pKa
into proper biological pH range.

RELATED APPLICATION

5

This application claims priority from co-pending provisional application Ser. No. 60/948,287, which was filed on 6
Jul. 2007, and which is incorporated herein by reference in its
entirety.

lO

FIELD OF THE INVENTION
The present invention relates to the field of cellular and
biological chemistry and, more particularly, to compounds
useful as fluorescent pH probes in biological systems.

15

BACKGROUND OF THE INVENTION
The dynamics of intracellular pH are believed to be crucial
for understanding the regulation mechanism of many physiological functions. I Of the methods available to determine
pH, optical methods have several advantages. These include a
rapid response time and a high signal-to-noise ratio. Additionally, they are non-invasive, and they generally have excellent pH sensitivity. Since the first use of a trapped intracellular
pH probe. 6-carboxyfluorescein, was described by Thomas et
al. I 2-3 I a large number of intracellular pH indicators has been
reported. I .4-I I However, these one-photon excited fluorescent
pH indicators have serious limitations, e.g. the interference of
autotluorescence and scattering from biological fluids and
tissue, photodamage of the samples and photo bleaching of
the indicators, difficulty in analyzing intercellular or intracellular pH differences, and others. Recently, using two-photon fluorescence (2 PF) to measure the pH has gained attention. I2-I5 Advantages of using the two-photon approach
include less scattering and deeper penetration in biological
samples by using NIR excitation light, less photodamage and
photobleaching, as well as the unique properties of obtaining
3D resolution. In addition to normal fluorescence methods, a
2 PF indicator has also been employed to detect the pH at
molecular level by using fluorescence correlation spectroscopy. I4 In order to quantitatively measure pH, the pK, of the
indicator needs to match with the pH of the experimental
system. Since the pH in the cell cytosol is typically between
6.8 and 7.4, there is tremendous interest in the development of
an efficient two-photon absorbing (2PA), near-neutral, fluorescent pH indicator. However, near-neutral 2 PF pH indicators are rare and the 2PA cross-sections of most commercial
pH indicators in the NIR region are low. I2-I 5 Only recently,
one example of a pH indicator designed with emphasis on
improving the two-photon absorptivity was reported by
Charier et al.I 3 A relatively high value of60 GM (1 GM=l050 cm4 s photon-I) was described, but its pKa of5.7 is too low
for near-neutral biological applications.
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Some of the features, advantages, and benefits of the
present invention having been stated, others will become
apparent as the description proceeds when taken in conjunction with the accompanying drawings, presented for solely
for exemplary purposes and not with intent to limit the invention thereto, and in which:
FIG. 1 shows the general structure offluorene derivatives
and a chemical synthesis of fluorescent probe 1 according to
an embodiment of the present invention;
FIG. 2 graphically illustrates the absorption, emission and
two-photon excitatin (2PE) spectra of (A) protonated form
leH+(in pH=4 buffer) and (B) neutral form le (in pH=lO
buffer)-absorption and fluorescence spectra are normalized;
FIG. 3 depicts the pH dependence of the absorption spectra
of probe le in buffer at 0.01 mM, with arrows indicating the
change of the absorption intensities with pH increase-the
inset shows the nonlinear fitting of the pH dependence of
molar extinction coefficients at 341 nm;
FIG. 4 shows pH-dependence of the fluorescence intensity
of le in buffer (10-5 M) excited at 355 nm-the inset is the
ratiometric calibration curves of /391//493 (intensity at 391
nm vs. intensity at isoemissive point 493 nm); and
FIG. 5 shows a 2 PF image ofNT2 cells incubated with le.
DETAILED DESCRIPTION OF THE PREFERRED
EMBODIMENT
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SUMMARY OF THE INVENTION
With the foregoing in mind, the present invention advantageously provides water-soluble fluorene derivatives with
pKa value near 7.
These compounds were synthesized and their potential as 2
PF pH indicators was evaluated. Their pKa value makes them
ideal for biological and biomedical imaging and diagnostic
applications.
The general structure of the fluorophore is shown in FIG. 1.
Fluorene derivative le has the same D-it-A type backbone

BRIEF DESCRIPTION OF THE DRAWINGS
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The present invention will now be described more fully
hereinafter with reference to the accompanying drawings, in
which preferred embodiments of the invention are shown.
Unless otherwise defined, all technical and scientific terms
used herein have the same meaning as commonly understood
by one of ordinary skill in the art to which this invention
pertains. Although methods and materials similar or equivalent to those described herein can be used in the practice or
testing of the present invention, suitable methods and materials are described below. Any publications, patent applications, patents, or other references mentioned herein are incorporated by reference in their entirety. In case of conflict, the
present specification, including any definitions, will control.
In addition, the materials, methods and examples given are
illustrative in nature only and not intended to be limiting.
Accordingly, this invention may, however, be embodied in
many different forms and should not be construed as limited
to the illustrated embodiments set forth herein. Rather, these
illustrated embodiments are provided so that this disclosure
will be thorough and complete, and will fully convey the
scope of the invention to those skilled in the art. Other features and advantages of the invention will be apparent from
the following detailed description, and from the claims.
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FIGS. 1through5 illustrate the presently disclosed invention, a two-photon absorbing, water soluble, fluorescent compound which is effective as a near-neutral pH indicator and,
particularly, as an intracellular pH probe.
The synthesis of the disclosed compounds is shown in the
chemical reactions depicted in FIG. 1. Converting the iodo
group in 2 into cyano in 3 gave the precursor that can be easily
hydrolyzed to carboxylic acid 4. The carboxylic acid was then
transformed to acid chloride in situ and reacted with aminothiophenol in DMSO to form the benzothioazole derivative. Two propionitrile groups were then introduced to 5 by a
Michael reaction. Subsequent reduction of the nitro to amino
group, diethylation of the amine with triethylphosphate, and
hydrolysis of the nitrile groups afforded the final product le in
good overall yield. All compounds were fully characterized
by NMR and elemental analysis (or HRMS in case of compounds with carboxylic acid moieties).
As expected, compound le exhibits adequate water solubility, i.e. >10-4 Mat pH 1-7 and >10- 3 Mat pH 7-12.At pH
4, the absorption and emission maxima of protonated le are
341 nm and 391 nm, respectively (FIG. 2, left panel) and a
fluorescence quantum yield of 0.21 was recorded. The 2PA
cross-section of the dye is very low in the excitation wavelength range of 570 nm to 7 50 nm, which may be attributed to
very strong electron withdrawing nature of the protonated
nitrogen of the diethylamino group (see the pKa measurement). In this nearly centrosymmetric A-it-A type structure,
the absorption wavelength is expected to shift to shorter
wavelength and the single photon excitation allowed S0-S 1
transition is not allowed by two-photon excitation. 19 In contrast, at pH 10 buffer, where a neutral form of le predominates, the absorption maxima is red shifted 41nmto382 nm,
and fluorescence quantum yield increased to 0.56 (FIG. 2,
right panel). In addition, a dramatic increase of 2PA crosssection to 99 GM at the excitation wavelength of 770 nm
occurred. Since the neutral form of dye le is a D-it-A type
structure, it is well-known that the single-photon excitation of
the allowed S0-S 1 also occurs via two-photon excitation,
which in this case is the absorption band at 382 nm. 19
The pH dependence of the absorption spectra when titrated
in aqueous buffer is shown in FIG. 4. With the increase of pH,
the absorption peak at 341 nm, attributed to the protonated
form of le, becomes weak and the absorption of the neutral
form at 382 nm appears with a well-defined isosbestic point.
It is known that the basicity of the nitrogen of diethylaminobenzene 20 is much stronger than the nitrogen in benzothiazole.21-22 Hence, the structure protonated form of le is
assigned as protonated at diethylamino site. The inset in FIG.
4 shows the results of the nonlinear regression of the E at 341
nm according to an existing method23 which gave a pKa value
of 6.95±0.01. The pKa value may also be calculated from pH
dependence of the integrated fluorescence of 1c excited at 340
nm and 382 nm, taking advantage of well separated fluorescence bands of the two forms. By using similar nonlinear
regression, nearly the same pKa value was obtained
(6.96±0.04).
In practical applications, fluorescent indicators with ratiometric properties are highly desirable since the ratio of the
fluorescence intensity at peak wavelength vs insensitive isoemissive wavelength is constant, regardless of the change of
fluorophore concentration by photobleaching or change of
the external environment, such as ion concentration. When 1c
was excited at the wavelength of the isosbestic absorption
point (355 nm), the fluorescence from both protonated and
neutral forms was observed, as shown in FIG. 4. The distinguished isoemission point at 493 nm makes le an excellent
ratiometric pH indicator. Under two-photon excitation, the

fluorescence from the protonated form disappeared due to its
low 2PA cross-section, rendering it unsuitable as a two-photon ratiometric pH indicator. However, the high 2PA crosssection and high fluorescence quantum yield of the neutral
form makes it promising for a number of important applications in fluorescence correlation spectroscopy and intra and
extracelluar pH sensing.
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For intracellular applications, one major concern for the
probes is the cell permeativity of the indicator. Therefore, le
was incubated with NT2 (NTERA-2 is cl.DI [NT2/Dl])
cells. The two-photon fluorescence image of the stained cells
is shown in FIG. 5. The dye has good permeativity and disperses in the cytosol well. The cytotoxic effect of le on
proliferating cells is another parameter of primary interest,
particularly for any live-cell fluorescence imaging applications. AnAlamar Blue (AB) reduction analysis 24 was used to
assess the cytotoxicity of le on proliferating NT2 cells. The
cells were treated with different concentrations of compound
le (0.1 µM-100 µM) dissolved in buffer, and were also treated
with 10% AB solution. The observed fluorescence intensity
of AB reduction by cells treated with various doses of 1c was
similar to that observed for cells untreated without any fluorene probe (control) after 48 h, indicating low toxicity of le
over a relatively wide concentration range.
In summary, fluorene derivatives la, lb and le were synthesized and tested. Derivative le functions as a near-neutral
pH indicator with pKa of 6.96, confirmed by both absorption
and fluorescence methods. The distinct isoemissive point in
the fluorescence spectra at different pH levels, good dispersion in the cell cytosol, and low cytotoxicity indicates that le
satisfies all the criteria for an excellent ratiomeric fluorescent
pH indicator. Furthermore, its high 2PA cross-section also
shows it has great potential for 3D pH fluorescence mapping
in live and fixed cells, as demonstrated in FIG. 5.
The invention, therefore, includes a fluorescent compound
preferably according to formula 1c, as shown below, wherein
R 1=ethyl and R 2=C 2H4COOH.

Compound le
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Another compound according to the invention has formula
la, as shown below, wherein R 1=phenyl and R 2=C 10 H 21 .
55
Compound la
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A third compound according to the invention has formula
1b, as shown below, wherein R 1=phenyl and
R 2=C 2H40C 2H40CH 3.
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The invention additionally includes a biologically compatible composition containing preferred compound le, but the
composition may contain compounds 1a, 1b, or combinations
of all three compounds. A biologically compatible composition is one which is compatible with the fluorescent compounds herein disclosed, for example, by not quenching the
fluorescence, and which can safely be administered to living
cells without causing undue toxicity to the cells. An example
of such a biologically compatible composition would be a
buffering solution.
Another aspect of the invention is a method of sensing pH
inside a cell, the method comprising introducing the fluorescent compound into the cell and irradiating the cell with a
near-infrared wavelength. More broadly, a method of sensing
pH inside a cell may comprise introducing the fluorescent
compound into the cell and irradiating the cell with a wavelength effective for exciting the compound to fluoresce
approximately at a predetermined pH. On a larger scale, the
method of sensing pH may be applied to a biological sample,
the method comprising contacting the biological sample with
the fluorescent compound and irradiating the biological
sample with a near-infrared wavelength. Likewise, in the
method comprising contacting the biological sample with the
fluorescent compound, irradiating the biological sample may
be accomplished with a wavelength effective for exciting the
compound to fluoresce approximately at a predetermined pH.
The present invention also includes a method of synthesizing a two-photon absorbing, near-neutral, pH indicator fluorescent when excited by light of a near-infrared wavelength
and having a formula selected from compounds 1a, 1b and 1c.
The method of synthesis comprises a reaction sequence
according to Scheme 1, as set forth in FIG. 1.
Accordingly, in the drawings and specification there have
been disclosed typical preferred embodiments of the invention and although specific terms may have been employed, the
terms are used in a descriptive sense only and not for purposes
of limitation. The invention has been described in considerable detail with specific reference to these illustrated embodiments. It will be apparent, however, that various modifications and changes can be made within the spirit and scope of
the invention as described in the foregoing specification and
as defined in the appended claims.
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and wherein R 1 =ethyl and R 2 =C 2 H4 COOH.
2. A composition containing the fluorescent compound of
claim 1.
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